Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: A review

Prenatal Diagnosis

Volumn 33, Issue 9, 2013, Pages 815-822

  Lindenburg, Irene T M ^a   van Klink, Jeanine M ^a   Smits Wintjens, Vivianne E H J ^a   van Kamp, Inge L ^a   Oepkes, Dick ^a   Lopriore, Enrico ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLEEDING; BRAIN INJURY; ERYTHEMA INFECTIOSUM; FETUS ANEMIA; FETUS DISEASE; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; NERVE CELL DIFFERENTIATION; OUTCOME ASSESSMENT; OXYGEN SUPPLY; POLYCYTHEMIA; PRIORITY JOURNAL; REVIEW; SURVIVOR;

PARVOVIRUS;

ANEMIA; BLOOD TRANSFUSION, INTRAUTERINE; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CHILD; CHILD DEVELOPMENT; COGNITION; DEVELOPMENTAL DISABILITIES; ERYTHROBLASTOSIS, FETAL; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; PREGNANCY; TREATMENT OUTCOME;

EID: 84883453029     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4152     Document Type: Review

References (51)

1. Rodeck CH, Kemp JR, Holman CA, et al. Direct intravascular fetal blood transfusion by fetoscopy in severe Rhesus isoimmunisation. Lancet 1981;1(8221):625-7.
2. Van Kamp IL, Klumper FJ, Oepkes D, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005;192:171-7.
3. Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2008;112(1):164-76.
4. Bennebroek Gravenhorst J, Kanhai HH, Meerman RH, et al. Twenty-two years of intra-uterine intraperitoneal transfusions. Eur J Obstet Gynecol Reprod Biol 1989;33:71-7.
5. Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J 1963;ii:1107-9.
6. Giacoia GP. Severe fetomaternal hemorrhage: a review. Obstet Gynecol Surv. 1997 Jun;52(6):372-80.
7. Van Kamp IL, Klumper FJ, Meerman RH, et al. Treatment of fetal anemia due to red cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. Leiden, Acta Obstet Gynecol Scand 2004;83(8):731-7.
8. Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2008;112(1):164-76.
9. Tiblad E, Kublickas M, Ajne G, et al. Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm. Fetal Diagn Ther 2011;30:266-73.
10. Lindenburg ITM, van Kamp IL, van Zwet EW, et al. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20weeks' gestation. BJOG 2013;120(7):847-52.
11. Nagel HT, de Haan TR, Vandenbussche FP, et al. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol. 2007;109(1):42-7.
12. Enders M, Weidner A, Zoellner I, et al. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004;24:513-8.
13. Dembinski J, Haverkamp F, Maara H, et al. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG 2002;109:1232-4.
14. De Jong EP, Lindenburg IT, van Klink JM, et al. Intrauterine transfusion for parvovirus B19 infection: long-term neurodevelopmental outcome. Am J Obstet Gynecol 2012;206(3):204.e1-5.
15. Barker DJ, Osmond C, Golding J, et al. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989;298:564-7.
16. Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338(12):798-803.
17. Leijser LM, Vos N, Walther FJ, et al. Brain ultrasound findings in neonates treated with intrauterine transfusion for fetal anaemia. Early Hum Dev. 2012;88(9):717-24.
18. Whyte RK. Neurodevelopmental outcome of extremely low-birth-weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Semin Perinatol. 2012;36(4):290-3.
19. Doyle LW, Kelly EA, Rickards AL, et al. Sensorineural outcome at 2years for survivors of erythroblastosis treated with fetal intravascular transfusions. Obstet Gynecol 1993;81:931-5.
20. Stewart G, Day RE, Del PC, et al. Developmental outcome after intravascular intrauterine transfusion for rhesus haemolytic disease. Arch Dis Child Fetal Neonatal Ed 1994;70:F52-3.
21. Janssens HM, de Haan MJ, van Kamp IL, et al. Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. J Pediatr 1997;131:373-80.
22. Hudon L, Moise Jr KJ, Hegemier SE, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease. Am J Obstet Gynecol 1998;179:858-63.
23. Grab D, Paulus WE, Bommer A, et al. Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years. Obstet Gynecol 1999;93:165-8.
24. Farrant B, Battin M, Roberts A. Outcome of infants receiving in-utero transfusions for haemolytic disease. NZ Med J 2001;114:400-3.
25. Hillman SC, Morris RK, Kilby MD. Co-twin prognosis after single fetal death: a systematic review and meta-analysis. Obstet Gynecol. 2011;118(4):928-40.
26. Harper DC, Swingle HM, Weiner CP, et al. Long-term neurodevelopmental outcome and brain volume after treatment for hydrops fetalis by in utero intravascular transfusion. Am J Obstet Gynecol 2006;195:192-200.
27. Weisz B, Rosenbaum O, Chayen B, et al. Outcome of severely anaemic fetuses treated by intrauterine transfusions. Arch Dis Child Fetal Neonatal Ed 2009;94:F201-4.
28. Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol 2012;206:141.e1-8.
29. Himpens E, Van den Broeck C, Oostra A, et al. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol 2008;50:334-40.
30. Moster D, Wilcox AJ, Vollset SE, et al. Cerebral palsy among term and postterm births. JAMA 2010;304:976-82.
31. Pistorius LR, Smal J, de Haan TR, et al. Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection. Fetal Diagn Ther 2008;24:491-4.
32. Miller E, Fairley CK, Cohen BJ, et al. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998;105(2):174-8.
33. Fay RA. Fetomaternal haemorrhage as a cause of fetal morbidity and mortality. Br J Obstet Gynaecol 1983;90:443-446.
34. Boyce LH, Khandji AG, DeKlerk AM, et al. Fetomaternal hemorrhage as an etiology of neonatal stroke. Pediatr Neurol 1994;11:255-257.
35. de Almeida V, Bowman JM. Massive fetomaternal hemorrhage: Manitoba experience. Obstet Gynecol. 1994 Mar;83(3):323-8.
36. Kecskes Z. Large fetomaternal hemorrhage: clinical presentation and outcome. J Matern Fetal Neonatal Med 2003;13: 128-32.
37. Rubod C, Deruelle P, Le Goueff F, et al. Long-term prognosis for infants after massive fetomaternal hemorrhage. Obstet Gynecol. 2007;110(2 Pt 1):256-60.
38. Lopriore E, Middeldorp JM, Oepkes D, et al. Twin anemia-polycythemia sequence in two monochorionic twin pairs without oligopolyhydramnios sequence. Placenta 2007;28:47-51.
39. Robyr R, Lewi L, Salomon LJ, et al. Prevalence and management of late fetal complications following successful selective laser coagulation of chorionic plate anastomoses in twin-to-twin transfusion syndrome. Am J Obstet Gynecol 2006;194:796-803.
40. Lopriore E, Slaghekke F, Oepkes D, et al. Clinical outcome in neonates with twin anemia-polycythemia sequence. Am J Obstet Gynecol. 2010;203(1):54.e1-5.
41. Genova L, Slaghekke F, Klumper FJ, et al. Management of twin anemia-polycythemia sequence using intrauterine blood transfusion for the donor and partial exchange transfusion for the recipient. Fetal Diagn Ther, DOI: 10.1159/000346413.
42. Lopriore E, Slaghekke F, Kersbergen K, et al. Severe cerebral injury in a recipient with twin anemia-polycythemia sequence. Ultrasound Obstet Gynecol. 2012, DOI: 10.1002/uog.12337
43. Lopriore E, Ortibus E, Acosta-Rojas R, et al. Risk factors for neurodevelopment impairment in twin-twin transfusion syndrome treated with fetoscopic laser surgery. Obstet Gynecol. 2009;113(2 Pt 1):361-6.
44. Oberhoffer R, Grab D, Keckstein J, et al. Cardiac changes in fetuses secondary to immune hemolytic anemia and their relation to hemoglobin and catecholamine concentrations in fetal blood. Ultrasound Obstet Gynecol. 1999;13(6):396-400.
45. Davis L, Roullet JB, Thornburg KL, et al. Augmentation of coronary conductance in adult sheep made anaemic during fetal life. J Physiol. 2003;547(Pt 1):53-9.
46. Bigras JL, Suda K, Dahdah NS, et al. Cardiovascular evaluation of fetal anemia due to alloimmunization. Fetal Diagn Ther. 2008;24(3):197-202.
47. Carter BS, DiGiacomo JE, Balderston SM, et al. Disproportionate septal hypertrophy associated with erythroblastosis fetalis. Am J Dis Child. 1990;144(11):1225-8.
48. Dickinson JE, Sharpe J, Warner TM, et al. Childhood cardiac function after severe maternal red cell isoimmunization. Obstet Gynecol. 2010;116(4):851-7.
49. Molina KM, Garcia X, Denfield SW, et al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol. 2013;34(2):390-7.
50. McCarthy RE 3rd, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342(10):690-5.
51. Amabile N, Fraisse A, Bouvenot J, et al. Outcome of acute fulminant myocarditis in children. Heart. 2006;92(9):1269-73.